BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Northup PG, Abecassis MM, Englesbe MJ, Emond JC, Lee VD, Stukenborg GJ, Tong L, Berg CL; Adult-to-Adult Living Donor Liver Transplantation Cohort Study Group. Addition of adult-to-adult living donation to liver transplant programs improves survival but at an increased cost. Liver Transpl 2009;15:148-62. [PMID: 19177435 DOI: 10.1002/lt.21671] [Cited by in Crossref: 34] [Cited by in F6Publishing: 25] [Article Influence: 2.6] [Reference Citation Analysis]
Number Citing Articles
1 Guler N, Yaprak O, Gunay Y, Dayangac M, Akyildiz M, Yuzer F, Yuzer Y, Tokat Y. Major complications of adult right lobe living liver donors. Hepatobiliary & Pancreatic Diseases International 2015;14:150-6. [DOI: 10.1016/s1499-3872(15)60346-0] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
2 Axelrod DA. Economic and financial outcomes in transplantation: whose dime is it anyway? Curr Opin Organ Transplant. 2013;18:222-228. [PMID: 23449346 DOI: 10.1097/mot.0b013e32835f0757] [Cited by in Crossref: 23] [Cited by in F6Publishing: 8] [Article Influence: 2.6] [Reference Citation Analysis]
3 Segedi M, Dhani G, Ng VL, Grant D. Living Donors for Fulminant Hepatic Failure in Children. In: Greenberg RA, Goldberg AM, Rodríguez-arias D, editors. Ethical Issues in Pediatric Organ Transplantation. Cham: Springer International Publishing; 2016. pp. 19-41. [DOI: 10.1007/978-3-319-29185-7_2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
4 Burra P, Freeman R. Trends in liver transplantation 2011. J Hepatol 2012;56 Suppl 1:S101-11. [PMID: 22300460 DOI: 10.1016/S0168-8278(12)60011-7] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
5 Carpenter D, Chaudhry S, Samstein B. The Current State of Minimally Invasive Living Donor Hepatectomy. Curr Transpl Rep 2020;7:169-79. [DOI: 10.1007/s40472-020-00287-x] [Reference Citation Analysis]
6 Gao F, Xu X, Zhu YB, Wei Q, Zhou B, Shen XY, Ling Q, Xie HY, Wu J, Wang WL, Zheng SS. Impact of intra-operative cholangiography and parenchymal resection to donor liver function in living donor liver transplantation. Hepatobiliary Pancreat Dis Int 2014;13:259-63. [PMID: 24919608 DOI: 10.1016/s1499-3872(14)60252-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
7 Farhang Zangneh H, Wong WWL, Sander B, Bell CM, Mumtaz K, Kowgier M, van der Meer AJ, Cleary SP, Janssen HLA, Chan KKW, Feld JJ. Cost Effectiveness of Hepatocellular Carcinoma Surveillance After a Sustained Virologic Response to Therapy in Patients With Hepatitis C Virus Infection and Advanced Fibrosis. Clin Gastroenterol Hepatol. 2018;pii:S1542-3565(18)31394-6. [PMID: 30580095 DOI: 10.1016/j.cgh.2018.12.018] [Cited by in Crossref: 52] [Cited by in F6Publishing: 43] [Article Influence: 13.0] [Reference Citation Analysis]
8 Abu-gazala S, Olthoff KM. Status of Adult Living Donor Liver Transplantation in the United States. Gastroenterology Clinics of North America 2018;47:297-311. [DOI: 10.1016/j.gtc.2018.01.004] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 5.8] [Reference Citation Analysis]
9 Kosieradzki M, Lisik W, Rowiński W, Małkowski P. Progress in abdominal organ transplantation. Med Sci Monit 2011;17:RA282-91. [PMID: 22129915 DOI: 10.12659/msm.882119] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
10 Mazzaferro V, Bhoori S, Sposito C, Bongini M, Langer M, Miceli R, Mariani L. Milan criteria in liver transplantation for hepatocellular carcinoma: an evidence-based analysis of 15 years of experience. Liver Transpl. 2011;17 Suppl 2:S44-S57. [PMID: 21695773 DOI: 10.1002/lt.22365] [Cited by in Crossref: 320] [Cited by in F6Publishing: 296] [Article Influence: 32.0] [Reference Citation Analysis]
11 Navin PJ, Olson MC, Knudsen JM, Venkatesh SK. Elastography in the evaluation of liver allograft. Abdom Radiol (NY) 2021;46:96-110. [PMID: 31950204 DOI: 10.1007/s00261-019-02400-w] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
12 Jay CL, Skaro AI, Ladner DP, Wang E, Lyuksemburg V, Chang Y, Xu H, Talakokkla S, Parikh N, Holl JL. Comparative effectiveness of donation after cardiac death versus donation after brain death liver transplantation: Recognizing who can benefit. Liver Transpl. 2012;18:630-640. [PMID: 22645057 DOI: 10.1002/lt.23418] [Cited by in Crossref: 55] [Cited by in F6Publishing: 51] [Article Influence: 5.5] [Reference Citation Analysis]
13 Prasad KR, Young RS, Burra P, Zheng SS, Mazzaferro V, Moon DB, Freeman RB. Summary of candidate selection and expanded criteria for liver transplantation for hepatocellular carcinoma: a review and consensus statement. Liver Transpl. 2011;17 Suppl 2:S81-S89. [PMID: 21748847 DOI: 10.1002/lt.22380] [Cited by in Crossref: 42] [Cited by in F6Publishing: 44] [Article Influence: 4.2] [Reference Citation Analysis]
14 Kumaran V. Role of liver transplantation for hepatocellular carcinoma. J Clin Exp Hepatol. 2014;4:S97-S103. [PMID: 25755618 DOI: 10.1016/j.jceh.2014.01.002] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
15 Aktaş S, Sevmiş Ş, Şeker M, Korkut E, Karakayalı H. Analysis of risk factors affecting coagulopathy after donor hepatectomy in a newly established liver transplant center. Turk J Surg 2017;33:69-75. [PMID: 28740953 DOI: 10.5152/turkjsurg.2017.3352] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
16 Gali B, Rosen CB, Plevak DJ. Living Donor Liver Transplantation: Selection, Perioperative Care, and Outcome. J Intensive Care Med 2012;27:71-8. [DOI: 10.1177/0885066610394313] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
17 Abecassis M. Making dollars and sense out of liver transplantation: Editorial. Liver Transpl 2009;15:1159-61. [DOI: 10.1002/lt.21851] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
18 Toro-Díaz H, Mayorga ME, Barritt AS, Orman ES, Wheeler SB. Predicting Liver Transplant Capacity Using Discrete Event Simulation. Med Decis Making 2015;35:784-96. [PMID: 25391681 DOI: 10.1177/0272989X14559055] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
19 Koning L, de Knegt RJ, Metselaar HJ. Living donor liver transplantation in HCV-infected patients: improvement of the donor risk-recipient benefit ratio is around the corner. Transpl Int 2014;27:765-6. [PMID: 24811090 DOI: 10.1111/tri.12351] [Reference Citation Analysis]
20 Yount KW, Turrentine FE, Lau CL, Jones RS. Putting the value framework to work in surgery. J Am Coll Surg 2015;220:596-604. [PMID: 25728143 DOI: 10.1016/j.jamcollsurg.2014.12.037] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
21 Holtzman S, Clarke HA, McCluskey SA, Turcotte K, Grant D, Katz J. Acute and chronic postsurgical pain after living liver donation: Incidence and predictors. Liver Transpl 2014;20:1336-46. [PMID: 25045167 DOI: 10.1002/lt.23949] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 2.9] [Reference Citation Analysis]
22 García-valdecasas J. Split and living donor liver transplantation. Digestive and Liver Disease Supplements 2009;3:93-5. [DOI: 10.1016/s1594-5804(09)60033-4] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
23 Kensinger CD, Dageforde LA, Moore DE. Can donors with high donor risk indices be used cost-effectively in liver transplantation in US Transplant Centers? Transpl Int 2013;26:1063-9. [DOI: 10.1111/tri.12184] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
24 Axelrod DA, Gheorghian A, Schnitzler MA, Dzebisashvili N, Salvalaggio PR, Tuttle-newhall J, Segev DL, Gentry S, Hohmann S, Merion RM, Lentine KL. The Economic Implications of Broader Sharing of Liver Allografts: Economics of Liver Allocation. American Journal of Transplantation 2011;11:798-807. [DOI: 10.1111/j.1600-6143.2011.03443.x] [Cited by in Crossref: 36] [Cited by in F6Publishing: 32] [Article Influence: 3.3] [Reference Citation Analysis]
25 Lim KC, Wang VW, Siddiqui FJ, Shi L, Chan ES, Oh HC, Tan SB, Chow PK. Cost-effectiveness analysis of liver resection versus transplantation for early hepatocellular carcinoma within the Milan criteria. Hepatology 2015;61:227-37. [PMID: 24638991 DOI: 10.1002/hep.27135] [Cited by in Crossref: 51] [Cited by in F6Publishing: 47] [Article Influence: 7.3] [Reference Citation Analysis]
26 Berumen J, Misel M, Vodkin I, Halldorson JB, Mekeel KL, Hemming A. The effects of Share 35 on the cost of liver transplantation. Clin Transplant 2017;31:e12937. [DOI: 10.1111/ctr.12937] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
27 Alves RC, Fonseca EA, Mattos CA, Abdalla S, Gonçalves JE, Waisberg J. Predictive factors of early graft loss in living donor liver transplantation. Arq Gastroenterol 2012;49:157-61. [PMID: 22767004 DOI: 10.1590/s0004-28032012000200011] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
28 Suh CH, Kim KW, Park SH, Kim SY, Woo D, Shin S, Pyo J, Shinagare AB, Ramaiya NH, Lim Y. Performing Gadoxetic Acid–Enhanced MRI After CT for Guiding Curative Treatment of Early-Stage Hepatocellular Carcinoma: A Cost-Effectiveness Analysis. American Journal of Roentgenology 2018;210:W63-9. [DOI: 10.2214/ajr.17.18300] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]